225 related articles for article (PubMed ID: 33647388)
1. Radiolabeled nanobodies for tumor targeting: From bioengineering to imaging and therapy.
Piramoon M; Khodadust F; Hosseinimehr SJ
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188529. PubMed ID: 33647388
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic biomolecules specific nanobodies application in cancer imaging and therapy; review and updates.
Shoari A; Tahmasebi M; Khodabakhsh F; Cohan RA; Oghalaie A; Behdani M
Int Immunopharmacol; 2022 Apr; 105():108585. PubMed ID: 35131732
[TBL] [Abstract][Full Text] [Related]
3. Immunotoxins and nanobody-based immunotoxins: review and update.
Khirehgesh MR; Sharifi J; Safari F; Akbari B
J Drug Target; 2021 Sep; 29(8):848-862. PubMed ID: 33615933
[TBL] [Abstract][Full Text] [Related]
4. Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.
D'Huyvetter M; Xavier C; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
Expert Opin Drug Deliv; 2014 Dec; 11(12):1939-54. PubMed ID: 25035968
[TBL] [Abstract][Full Text] [Related]
5. Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy.
Sun S; Ding Z; Yang X; Zhao X; Zhao M; Gao L; Chen Q; Xie S; Liu A; Yin S; Xu Z; Lu X
Int J Nanomedicine; 2021; 16():2337-2356. PubMed ID: 33790553
[TBL] [Abstract][Full Text] [Related]
6. Nanobodies and their potential applications.
Hassanzadeh-Ghassabeh G; Devoogdt N; De Pauw P; Vincke C; Muyldermans S
Nanomedicine (Lond); 2013 Jun; 8(6):1013-26. PubMed ID: 23730699
[TBL] [Abstract][Full Text] [Related]
7. Nanobodies and Cancer: Current Status and New Perspectives.
Allegra A; Innao V; Gerace D; Vaddinelli D; Allegra AG; Musolino C
Cancer Invest; 2018 Apr; 36(4):221-237. PubMed ID: 29658806
[TBL] [Abstract][Full Text] [Related]
8. Antibody-based Radiopharmaceuticals as Theranostic Agents: An Overview.
Sharma R; Suman SK; Mukherjee A
Curr Med Chem; 2022; 29(38):5979-6005. PubMed ID: 35674298
[TBL] [Abstract][Full Text] [Related]
9. Nanobodies as versatile tools: A focus on targeted tumor therapy, tumor imaging and diagnostics.
Al-Baradie RS
Hum Antibodies; 2020; 28(4):259-272. PubMed ID: 32831197
[TBL] [Abstract][Full Text] [Related]
10. Nanobodies: from structure to applications in non-injectable and bispecific biotherapeutic development.
Li B; Qin X; Mi LZ
Nanoscale; 2022 May; 14(19):7110-7122. PubMed ID: 35535618
[TBL] [Abstract][Full Text] [Related]
11. A guide to: generation and design of nanobodies.
Muyldermans S
FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
[TBL] [Abstract][Full Text] [Related]
12. Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review).
Yu S; Xiong G; Zhao S; Tang Y; Tang H; Wang K; Liu H; Lan K; Bi X; Duan S
Int J Mol Med; 2021 Feb; 47(2):444-454. PubMed ID: 33416134
[TBL] [Abstract][Full Text] [Related]
13. Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy.
Hu Y; Liu C; Muyldermans S
Front Immunol; 2017; 8():1442. PubMed ID: 29163515
[TBL] [Abstract][Full Text] [Related]
14. Nanobodies as Versatile Tool for Multiscale Imaging Modalities.
Erreni M; Schorn T; D'Autilia F; Doni A
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33353213
[TBL] [Abstract][Full Text] [Related]
15. Nanobody-based therapeutics against colorectal cancer: Precision therapies based on the personal mutanome profile and tumor neoantigens.
Moradi A; Pourseif MM; Jafari B; Parvizpour S; Omidi Y
Pharmacol Res; 2020 Jun; 156():104790. PubMed ID: 32278043
[TBL] [Abstract][Full Text] [Related]
16. Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer.
Van Audenhove I; Gettemans J
EBioMedicine; 2016 Jun; 8():40-48. PubMed ID: 27428417
[TBL] [Abstract][Full Text] [Related]
17. Targeting tumors with nanobodies for cancer imaging and therapy.
Oliveira S; Heukers R; Sornkom J; Kok RJ; van Bergen En Henegouwen PM
J Control Release; 2013 Dec; 172(3):607-17. PubMed ID: 24035975
[TBL] [Abstract][Full Text] [Related]
18. Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.
Wang J; Kang G; Yuan H; Cao X; Huang H; de Marco A
Front Immunol; 2021; 12():838082. PubMed ID: 35116045
[TBL] [Abstract][Full Text] [Related]
19. [Progress in nanobody and its application in diagnosis].
Kong Q; Yao Y; Chen R; Lu S
Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
[TBL] [Abstract][Full Text] [Related]
20. Nanobodies as therapeutics: big opportunities for small antibodies.
Steeland S; Vandenbroucke RE; Libert C
Drug Discov Today; 2016 Jul; 21(7):1076-113. PubMed ID: 27080147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]